Dr. Bryan Ardis talks warns that covid hospital protocols are needlessly killing patients – Brighteon.TV

The Thrive Time Show sat down with Dr. Bryan Ardis to talk about how COVID-19 protocols that hospitals are required to follow are actually killing patients.

According to Ardis, hospitals dictate the protocols for COVID-19 treatment, and among these protocols include the use of drugs remdesivir, dexamethasone, and vancomycin — drugs, that, together, can cause serious adverse effects to the body.

Ardis’s statements were backed by studies. (Related: Dr. Bryan Ardis exposes the truth behind COVID-19 protocols – Brighteon.TV.)

Specific antiviral treatments for COVID-19 have not been clearly identified; therefore, there had been several strategies proposed to treat patients. Using convalescent plasma and interferon, chloroquine and hydroxychloroquine, and interleukin 6 receptor inhibitors are some of these treatments. Ivermectin, which inhibits nuclear transport of viral proteins, is also on the list.

Remdesivir was previously used as a treatment of ebola, and has since been approved by the FDA for the treatment fo COVID-19 in certain situations.

Patients with mild clinical presentation who may not initially require hospitalization may manage their illness at home. However, the decision to monitor a patient in an in-patient or outpatient setting should be made on a case-to-case basis.

Ardis is making the case that the U.S. system has failed Americans. His father-in-law was recently taken to the hospital with a fever and a headache. Within days, his health deteriorated by developing pneumonia, and then kidney failure. Five days after he was admitted, Ardis claimed his father-in-law was barely conscious.

He then found that the hospital was treating him with antibiotics.

Moreover, tests came to how that his father came back negative for bacterial, viral or fungal infections.

Still, the hospital continued to treat him with antibiotics as per “protocol.”

“The only reason why you would do that is to cover up your crimes of murdering someone by drowning them to death, and we were able to prove to them that they were actually purposely doing that with an ill-advised hospital protocol,” Ardis said.

After consulting with the family, doctors injected morphine into his father-in-law, to relieve the pain. Except that Ardis believes they are murdering loved ones in front of you.

WHO recommends against use of remdesivir

This is the same case as with COVID-19 patients, using remdesivir, which was more dangerous than everyone thought.

The World Health Organization suggested that there is no important effect on mortality, need for mechanical ventilation, or other patient-important outcomes that result from the use of remdesivir.

The controversy surrounding remdesivir and other cocktail drugs shows conflicting evidence of their effectiveness. Some found that COVID patients who received the drug recovered faster with fewer deaths, while other studies showed that it did not reduce the length of hospitalization or death rate.

What is questionable is that remdesivir has not been held to the same standards as other candidates aiming to treat COVID-19. Even the vaccines, which have been developed faster than traditional drugs were able to pass the phase-3 clinical trials that test whether or not the drugs are safe and effective for use in people.

Remdesivir is also expensive, even though it is not guaranteed to save patients from COVID. It also has the flaw of being a high-dosage drug over a short time frame, which contributes to many adverse side effects. It does not prevent people from being infected by the SARS-CoV-2 virus, either. The virus’s genetic material mutates to create new strains of virus and variants of COVID-19, and thus there is a need for other alternative treatments to buy time for the development of newer vaccines.

Listen more about Dr. Ardis’s thoughts on using remdesivir and other drug cocktails to stop COVID-19 on the Thrive Time Show, Mondays at 3:30 PM on BrighteonTV.

Learn more at Pandemic.news.

Sources include:

Planet-Today.com

Forbes.com